|
2024
|
Invention
|
Multivalent streptococcus pneumoniae capsular polysaccharide-protein conjugate composition, prepa... |
|
|
Invention
|
Anti-neisseria meningitidis immune composition and use thereof. Provided is an immunogenic compos... |
|
|
Invention
|
Immune composition against meningococcus and use thereof. Provided is an immunogenic composition ... |
|
|
Invention
|
Method for characterizing inhalation vaccine performance. A method for characterizing inhalation ... |
|
|
Invention
|
Chimpanzee adenoviral vector-based vaccine liquid formulation and preparation method. The present... |
|
|
Invention
|
Adenoviral vector vaccine, and preparation method and use thereof. Provided are a modified recomb... |
|
|
Invention
|
Combined vaccine, and preparation method therefor and use thereof. Provided is a combined vaccine... |
|
|
Invention
|
Inhaled adenovirus vector vaccine, preparation method therefor and use thereof. The present inven... |
|
|
Invention
|
Pulmonary tuberculosis vaccine, preparation method therefor, and application thereof. Provided is... |
|
|
Invention
|
Method for purifying virus-like particles and use thereof. Provided is a purification process cap... |
|
|
Invention
|
Pertussis toxin detoxification method and diphtheria, tetanus and acellular pertussis combined va... |
|
2023
|
Invention
|
Recombinant poliovirus-like particle vaccine, preparation method therefor and use thereof. Provid... |
|
|
Invention
|
Vector for expressing poliovirus-like particles, preparation method therefor, and use thereof. Pr... |
|
|
Invention
|
Recombinant poliovirus-like particle, preparation method therefor, and use. Provided are a recomb... |
|
|
Invention
|
Atomization inhalation bag and use thereof in atomization inhalation administration. Disclosed he... |
|
|
Invention
|
Nucleic acid-lipid nanoparticle composition, and lyophilized preparation thereof, preparation met... |
|
|
P/S
|
Pharmaceutical preparations, namely, antivirals; Chemical preparations for pharmaceutical purpose... |
|
|
Invention
|
Chimpanzee adenovirus vector-based liquid vaccine formulation and preparation method. Provided ar... |
|
|
Invention
|
Atomization-inhalation-type atomization drug administration device. An atomization-inhalation-typ... |
|
|
Invention
|
Adenoviral vector vaccine against respiratory syncytial virus, and preparation method therefor an... |
|
|
Invention
|
Freeze-drying protective agent for nucleic acid-lipid nanoparticles, preparation method therefor,... |
|
|
Invention
|
Atomization drug delivery device and use thereof in inhalation vaccine. An atomization drug deliv... |
|
|
Invention
|
Pen-shaped drug delivery device for inhalation of nebulized drugs. Provided is a pen-shaped drug ... |
|
|
Invention
|
Novel ionizable lipid used for nucleic acid delivery and lnp composition thereof and vaccine. The... |
|
|
Invention
|
Novel ionizable lipid for nucleic acid delivery, and lnp composition and vaccine thereof. The pre... |
|
|
Invention
|
Novel ionizable lipid used for nucleic acid delivery as well as lnp composition and vaccine there... |
|
|
Invention
|
Carrier protein subjected to site-directed mutation and use thereof in preparation of vaccine.
P... |
|
2022
|
Invention
|
Cup having atomizing inhalation function. A cup having an atomizing inhalation function, comprisi... |
|
|
Invention
|
Mrna sars-cov-2 vaccine, method for preparing same, and use thereof. Disclosed are an mRNA SARS-C... |
|
|
Invention
|
Inhalation administration delivery system of recombinant adenovirus vector vaccine. Disclosed is ... |
|
|
Invention
|
Nebulizer cup and use thereof in nebulization inhalation administration.
Disclosed are a nebuliz... |
|
|
Invention
|
Nebulizer cup and use thereof in nebulization inhalation administration. A nebulizer cup and a us... |
|
|
P/S
|
Medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, o... |
|
|
P/S
|
Pharmaceutical preparations for use as anti-infectives; biological preparations made from living ... |
|
|
P/S
|
Medicines for human purposes; biological preparations for
medical purposes; pharmaceutical prepa... |
|
|
Invention
|
Streptococcus pneumoniae conjugate vaccine composition. The present invention provides a glycocon... |
|
|
Invention
|
Method for preparing pneumococcal-binding vaccine. A glycoconjugate, a specific method for prepar... |
|
|
P/S
|
Medicines for human purposes; pharmaceutical preparations;
vaccines; biological preparations for... |
|
2021
|
P/S
|
medicines for human purposes; biological preparations for medical purposes; pharmaceutical prepar... |
|
|
Invention
|
Pharmaceutical composition and use thereof. Disclosed are a pharmaceutical composition and the us... |
|
|
Invention
|
Method for preparing adenovirus vector vaccine by means of perfusion culture process.
Provided i... |
|
|
Invention
|
Method for preparing adenovirus vector vaccine by means of perfusion culture process. Provided is... |
|
|
Invention
|
Mrna or mrna composition, and preparation method therefor and application thereof. Provided are a... |
|
|
Invention
|
Carrier protein subjected to site-directed mutation and use thereof in preparation of vaccine. Pr... |
|
|
Invention
|
Sars-cov-2 vaccine.
Disclosed is a SARS-CoV-2 vaccine, wherein the S protein of SARS-CoV-2 serve... |
|
|
Invention
|
Sars-cov-2 vaccine. Disclosed is a SARS-CoV-2 vaccine, for which the S protein of SARS-CoV-2 serv... |
|
|
Invention
|
Mrna vaccine for 2019-ncov coronavirus, preparation method and application thereof. Provided are ... |
|
|
P/S
|
Medicines for human purposes to treat infectious diseases, namely, covid-19, coronavirus diseases... |
|
2020
|
Invention
|
Carrier protein with site-directed mutation and use thereof in preparation of vaccine.
The prese... |
|
|
Invention
|
Carrier protein with site-directed mutation and use thereof in preparation of vaccine. Provided i... |
|
|
Invention
|
Recombinant novel coronavirus vaccine using replication-deficient human adenovirus as vector.
Pr... |
|
|
Invention
|
Recombinant novel coronavirus vaccine using replication-deficient human adenovirus as vector. Pro... |
|
|
Invention
|
Glycoconjugate and use thereof. Provided are a glycoconjugate, a specific preparation method for ... |
|
|
Invention
|
Cell strain for reducing production of replication competent adenovirus, and construction method ... |
|
|
Invention
|
Samrna vaccine and preparation method therefor.
Disclosed is an SamRNA vaccine, including a reco... |
|
|
Invention
|
Samrna vaccine and preparation method therefor. Disclosed is a SamRNA vaccine, the vaccine compri... |
|
2018
|
P/S
|
vaccines; drugs for medical purposes, namely, pharmaceuticals for meningococcal vaccine; diagnost... |
|
|
P/S
|
Vaccines; drugs for medical purposes; diagnostic
preparations for medical purposes; cultures of
... |
|
|
Invention
|
Cell strain for reducing production of reproducible adenovirus, and construction method and use. ... |
